A recent pilot study indicates that a specific low-viscosity, short-chain oat fiber supplement may help stabilize blood glucose levels and reduce gastrointestinal discomfort. Researchers found that participants who consumed this …
Tag:
Placebo
-
-
Regeneron’s Maftivimab, Mapp’s MBP134, and Gilead’s Remdesivir Highlight Ongoing Efforts in Antiviral Development Regeneron’s monoclonal antibody maftivimab, Mapp Biopharmaceuticals’ MBP134, and Gilead Sciences’ remdesivir are among the therapies being prioritized …
-
Retatrutide and the Future of Obesity Treatment: Insights from the TRIUMPH-1 Study The landscape of obesity medicine is evolving rapidly. Eli Lilly’s investigational drug, retatrutide, has recently garnered significant attention …
-
Caffeine vs. Exercise vs. Placebo: What Actually Works for Mental Fatigue? By Dr. Natalie Singh, Health Editor | May 11, 2026 If you’ve ever pushed through a long workday feeling …
-
Health
Alzheimer’s Drug Failures: Monoclonal Antibodies and Anti-Amyloid Treatments Show No Clinically Meaningful Benefit, Review Finds
Anti-amyloid Alzheimer’s Drugs Show No Clinically Meaningful Effect, Major Review Finds Recent analysis of anti-amyloid monoclonal antibody treatments for Alzheimer’s disease reveals these medications provide little to no meaningful benefit …
-
Exercise and Ibuprofen May Help Reduce Cognitive Impairment During Chemotherapy A new Phase II clinical trial has found that both exercise and low-dose ibuprofen can help lessen cognitive problems in …
-
Weight Loss Drug Semaglutide Fails to Leisurely Alzheimer’s Progression Despite initial optimism stemming from observational studies and biomarker changes, recent Phase 3 clinical trials published in The Lancet have demonstrated …
-
Gut Microbiome May Predict Response to GLP-1 Weight Loss Medications New research highlights the growing understanding of how the gut microbiome influences the effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1 …
-
Chronic Back Pain Amplifies Sounds, Brain Research Reveals New Treatment Hope People with chronic back pain don’t just experience physical discomfort – they may also perceive everyday sounds as harsher …
-
Technology
Dapiglutide Trial: Dual Gut Hormone Agonist Shows Promise But Fails to Beat Placebo for Obesity
Dapiglutide: Novel GLP-1/GLP-2 Agonist Shows Promise in Early Obesity Trials A new drug, dapiglutide, combining GLP-1 and GLP-2 receptor activation, is being investigated as a potential treatment for obesity. Early …
Newer Posts